BioSpace News Archive

With the Identification of Six Genetic Mutations, Authors Urge Genetic Testing for All Pancreatic Cancer Patients - Not Only Those with a Family History

Grants made through Cardinal Health’s Opioid Action Program will support prevention education, best practices in pain medication use and community-wide efforts

Leading IPA’s investments and expansions ensure its present stability and future success

In the news release, Statement from the Co-Chairs of the Special Advisory Committee on the Epidemic of Opioid Overdoses and the Canadian Institute for Health Information on Updates to Data Related to the Opioid Crisis, issued 19-Jun-2018 by Health Canada (HC) over CNW Newswire, we are advised by Health Canada that in the second paragraph, the link to the “new data from emergency medical services” has changed. The complete, corrected release follows:

Hearst Health and the Jefferson College of Population Health at Thomas Jefferson University announced the panel of judges for the 2019 Hearst Health Prize.

Cambium Medical Technologies (“Cambium”), a clinical stage company, announced today first patient enrollment for its Elate Ocular™.

Leading BioSciences today reported positive interim data from the company’s ongoing Phase 2 clinical trial of its lead drug candidate, LB1148.

Clean Recovery Centers has announced a partnership with Steve Maraboli (www.stevemaraboli.net) a life-changing speaker, author, and leading Behavioral Scientist.

Please join Ontario Power Generation (OPG), BWXT Canada and University Health Network (UHN) for an important announcement.

Pomerantz LLP is investigating claims on behalf of investors of Valeant Pharmaceuticals International, Inc.